Royalty Pharma plc (NASDAQ:RPRX) EVP Sells $3,159,031.48 in Stock

Northeast Financial Consultants Inc lowered its position in shares of Merck & Co., Inc. (NYSE:MRK – Get Rating) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 74,965 shares of the company’s stock after selling 1,066 shares during the period. […]

Related Keywords

Alaska ,United States ,Robertm Davis ,Societe Generale ,Sanat Chattopadhyay ,Crescent Sterling Ltd ,Financial Consultants Inc ,Merck Co Inc ,Exchange Commission ,Ascent Wealth Partners ,News Ratings For Merck Co ,Insider Activity At Merck Co Inc ,Merck Co ,Quarter For Merck Co Inc ,Wealth Management ,Citigroup ,Securities Exchange Commission ,Berenberg Bank ,Animal Health ,Northeast Financial Consultants Inc ,Get Rating ,Wealth Partners ,Wealth Advisors ,Drive Wealth Management ,Trading Down ,Visit Holdingschannel ,Nyse Mrk ,Mrk ,Medical ,58933y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,